Skip to main content Accessibility help
×
Home

Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy

  • J. Van Der Veen (a1), M. F. W. Abarbanel (a1) and Kiem Giok Oei (a1)

Extract

Live type 4 adenovirus contained in enteric-coated tablets was given to 2628 military recruits. In two trials, the enteric adenovirus vaccine reduced febrile and afebrile adenovirus illness by about 90% or more. Moreover, a decided protective effect against subclinical adenovirus infection as evidenced by seroconversion was found.

The antibody-stimulating effect of enteric adenovirus vaccine was not an adequate measure of its protective capacity. The neutralizing antibody response of recruits given vaccine was poor in comparison with the antibody response to naturally acquired infection with type 4 adenovirus. The latter response was related to the severity of infection.

We are indebted to Colonel Dr B. J. W. Beunders, Head of the Division of Preventive Medicine of the Royal Netherlands Army, for granting us facilities to conduct this study and to Misses W. T. C. J. Smulders, E. M. J. C. Vallas, J. E. M. Dusseldorp and M. M. J. P. Keeris for their valuable technical assistance.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy
      Available formats
      ×

Copyright

References

Hide All
Chanock, R. M., Ludwig, W., Huebner, R. J., Cate, T. R. & Chu, L. W. (1966). Immunization by selective infection with Type 4 adenovirus grown in human diploid tissue culture. I. Safety and lack of oncogenicity and tests for potency in volunteers. J. Am. med. Ass. 195, 445.
Couch, R. B., Chanock, R. M., Cate, T. R., Lang, D. J., Knight, V. & Huebner, R. J. (1963). Immunization with Types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. resp. Dis. 88, 394.
Davenport, F. M. (1962). The development of adenovirus vaccines: progress and problems. Boerhaave–Cursus Respiratory Virus Disease Conference,Leiden, Holland, p. 12.
Edmondson, W. P., Purcell, R. H., Gundelfinger, B. F., Love, J. W. P., Ludwig, W. & Chanock, R. M. (1966). Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. Specific protective effect against epidemic disease. J. Am. med. Ass. 195, 453.
Gutekunst, R. R., White, R. J., Edmondson, W. P. & Chanock, R. M. (1967). Immunization with live Type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection. Am. J. Epidem. 86, 341.
Hilleman, M. R. (1957). Epidemiology of adenovirus respiratory infections in military recruit populations. Ann. N.Y. Acad. Sci. 67, 262.
Hilleman, M. R. (1966). Adenovirus: history and future of a vaccine. In Viruses Inducing Cancer, p. 377. Ed. Burdette, W. J.. Salt Lake City, Utah: University of Utah Press.
Meiklejohn, G. (1963). Present and future of inactivated virus vaccines. Am. Rev. resp. Dis. 88, 372.
Miller, L. F., Peckinpaugh, R. O., Arlander, T. R., Pierce, W. E., Edwards, E. A., de Berry, P., Phillips, I. A. & Rosenbaum, M. J. (1965). Epidemiology and prevention of acute respiratory disease in naval recruits. II. Efficacy of adjuvant and aqueous adenovirus vaccines in prevention of naval recruit respiratory disease. Am. J. publ. Hlth 55, 47.
Sever, J. L. (1962). Application of a microtechnique to viral serological investigations. J. Immun. 88, 320.
Truffelli, G. T., Timm, E. A., Beardmore, W. B. & McLean, I. W. (1967). Inactivation of adenovirus and simian virus 40 tumorigenicity in hamsters by vaccine processing methods. Appl. Microbiol. 15, 516.
van der Veen, J., van Zaane, D. J., Sprangers, M. A. J. & Heyen, C. F. A. (1967). Homotypic and heterotypic antibody response in infants to adenovirus vaccine. Arch. ges. Virusforsch. 21, 320.
van Eeden, C. & Rümke, C. L. (1961). A k sample trend test. Statistica Neerlandica 15, 25.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed